Abnormal cortisol metabolism and tissue sensitivity to cortisol in patients with glucose intolerance

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 12, 2002, Pages 5587-5593

  Andrews, Robert C ^a   Herlihy, Olive ^a   Livingstone, Dawn E W ^a   Andrew, Ruth ^a   Walker, Brian R ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; 11BETA HYDROXYSTEROID DEHYDROGENASE 1; BECLOMETASONE; CORTISONE; GLUCOCORTICOID; GLUCOSE; HEMOGLOBIN A1C; HYDROCORTISONE; HYDROCORTISONE DERIVATIVE; UNCLASSIFIED DRUG;

AGE; ARTICLE; BLOOD PRESSURE; BODY FAT; BODY MASS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GLUCOSE INTOLERANCE; HORMONE METABOLISM; HORMONE RELEASE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; HYDROCORTISONE URINE LEVEL; HYPERGLYCEMIA; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL;

ADMINISTRATION, TOPICAL; ANTI-INFLAMMATORY AGENTS; BECLOMETHASONE; DIABETES MELLITUS, TYPE 2; GLUCOSE INTOLERANCE; HUMANS; HYDROCORTISONE; HYPERGLYCEMIA; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; REFERENCE VALUES; SKIN; VASOCONSTRICTION;

EID: 0036925387     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-020048     Document Type: Article

References (70)

1. Reaven GM, Hoffman BB 1987 A role for insulin in the aetiology and course of hypertension. Lancet ii:435-436
2. Andrews RC, Walker BR 1999 Glucocorticoids and insulin resistance: Old hormones, new targets. Clin Sci 96:513-523
3. Bjorntorp P, Holm G, Rosmond R 1999 Hypothalamic arousal, insulin resistance and type 2 diabetes mellitus. Diabetic Med 16:373-381
4. Phillips DIW, Barker DJP, Fall CHD, Whorwood CB, Seckl JR, Wood PJ, Walker BR 1998 Elevated plasma cortisol concentrations: An explanation for the relationship between low birthweight and adult cardiovascular risk factors. J Clin Endocrinol Metab 83:757-760
5. Seckl JR, Walker BR 2001 11β-Hydroxysteroid dehydrogenase type 1 - A tissue-specific amplifier of glucocorticoid action. Endocrinology 142:1371-1376
6. Kotelevtsev YV, Holmes MC, Burchell A, Houston PM, Scholl D, Jamieson PM, Best R, Brown RW, Edwards CRW, Seckl JR, Mullins JJ 1997 11β-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid inducible responses and resist hyperglycaemia on obesity and stress. Proc Natl Acad Sci USA 94:14924-14929
7. Morton NM, Holmes MC, Fievet C, Staels B, Tailleux A, Mullins JJ, Seckl JR 2001 Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11β-hydroxysteroid dehydrogenase type 1 null mice. J Biol Chem 276:41293-41300
8. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS 2001 A transgenic model of visceral obesity and the metabolic syndrome. Science 294:2166-2170
9. Reichardt HM, Tronche F, Bauer A, Schutz G 2000 Molecular genetic analysis of glucocorticoid signaling using the Cre/loxP system. Biol Chem 381:961-964
10. Watt GCM, Harrap SB, Foy CJW, Holton DW, Edwards HV, Davidson HR, Connor JM, Lever AF, Fraser R 1992 Abnormalities of glucocorticoid metabolism and the renin-angiotensin system: A four corners approach to the identification of genetic determinants of blood pressure. J Hypertens 10:473-482
11. Filipovsky J, Ducimetiere P, Eschwege E, Richard JL, Rosselin G, Claude JR 1996 The relationship of blood pressure with glucose, insulin, heart rate, free fatty acids and plasma cortisol levels according to degree of obesity in middle-aged men. J Hypertens 14:229-235
12. Hautanen A, Raikkonen K, Adlercreutz H 1997 Associations between pituitary-adrenocortical traction and abdominal obesity, hyperinsulinaemia and dyslipidaemia in normotensive males. J Intern Med 241:451-461
13. Walker BR, Phillips DIW, Noon JP, Panarelli M, Best R, Edwards HE, Holton DW, Seckl JR, Webb DJ, Watt GCM 1998 Increased glucocorticoid activity in men with cardiovascular risk factors. Hypertension 31:891-895
14. Fraser R, Ingram MC, Anderson NH, Morrison C, Davies E, Connell JMC 1999 Cortisol effects on body mass, blood pressure, and cholesterol in the general population. Hypertension 33:1364-1368
15. Walker BR, Soderberg S, Lindahl B, Olsson T 2000 Independent effects of obesity and cortisol in predicting cardiovascular risk factors in men and women. J Intern Med 247:198-204
16. Reynolds RM, Walker BR, Phillips DIW, Sydall HE, Andrew R, Wood PJ, Whorwood CB 2001 Altered control of cortisol secretion in adult men with low birthweight and cardiovascular risk factors. J Clin Endocrinol Metab 86:245-250
17. Walker BR, Best R, Shackleton CHL, Padfield PL, Edwards CRW 1996 Increased vasoconstrictor sensitivity to glucocorticoids in essential hypertension. Hypertension 27:190-196
18. Rosmond R, Dallman MF, Bjorntorp P 1998 Stress-related cortisol secretion in men: Relationships with abdominal obesity and endocrine, metabolic and haemodynamic abnormalities. J Clin Endocrinol Metab 83:1853-1859
19. Reynolds RM, Sydall HE, Wood PJ, Phillips DIW, Walker BR 2001 Elevated plasma cortisol in glucose intolerant men: Different responses to glucose and habituation to venepuncture. J Clin Endocrinol Metab 86:1149-1153
20. Rask E, Olsson T, Soderberg S, Andrew R, Livingstone DEW, Johnson O, Walker BR 2001 Tissue-specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab 86:1418-1421
21. Ljung T, Andersson B, Bengtsson B, Bjorntorp P, Marin P 1996 Inhibition of cortisol secretion by dexamethasone in relation to body fat distribution: A dose-response study. Obes Res 4:277-282
22. Andrew R, Phillips DIW, Walker BR 1998 Obesity and gender influence cortisol secretion and metabolism in man. J Clin Endocrinol Metab 83:1806-1809
23. Strain GW, Zumoff B, Kream J, Strain JJ, Levin J, Fukushima D 1982 Sex difference in the influence of obesity on the 24 hr mean plasma concentration of cortisol. Metabolism 31:209-212
24. Walker BR, Stewart PM, Shackleton CHL, Padfield PL, Edwards CRW 1993 Deficient inactivation of cortisol by 11β-hydroxysteroid dehydrogenase in essential hypertension. Clin Endocrinol (Oxf) 39:221-227
25. Soro A, Ingram MC, Tonolo G, Glorioso N, Fraser R 1995 Evidence of coexisting changes in 11β-hydroxysteroid dehydrogenase and 5β-reductase activity in patients with untreated essential hypertension. Hypertension 25:67-70
26. Lovati E, Ferrari P, Dick B, Jostarndt K, Frey BM, Frey FJ, Schorr U, Sharma AM 1999 Molecular basis of human salt sensitivity: The role of the 11β-hydroxysteroid dehydrogenase type 2. J Clin Endocrinol Metab 84:3745-3749
27. Rask E, Walker BR, Soderberg S, Livingstone DEW, Eliasson M, Johnson O, Andrew R, Olsson T 2002 Tissue-specific changes in peripheral cortisol metabolism in obese women; increased adipose 11β-hydroxysteroid dehydrogenase type 1 activity. J Clin Endocrinol Metab 87:3330-3336
28. Paulmyer-Lacroix O, Boullu S, Oliver C, Alessi M-C, Grino M 2002 Expression of the mRNA coding for 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue from obese patients: An in situ hybridization study. J Clin Endocrinol Metab 87:2701-2705
29. Walker BR, Connacher AA, Lindsay RM, Webb DJ, Edwards CRW 1995 Carbenoxolone increases hepatic insulin sensitivity in man: A novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation. J Clin Endocrinol Metab 80:3155-3159
30. Walker BR 2000 How will we know if 11β-hydroxysteroid dehydrogenases are important in common diseases? Clin Endocrinol (Oxf) 52:401-402
31. Mortimore GE, Irvine E, Hopper J, Forsham PH 1956 The functional state of the adrenal cortex in diabetes mellitus. J Clin Endocrinol Metab 16:932-936
32. Lentle BC, Thomas JP1964 Adrenal function and the complications of diabetes mellitus. Lancet 545-549
33. Charro-Salgado AL, Clarke BF, Shackleton CHL, Duncan LJP, Mitchell FL 1968 Urinary steroid excretion patterns in diabetes mellitus. Lancet i:126-127
34. Cameron OG, Kronfol Z, Greden JF, Carroll BJ 1984 Hypothalamic-pituitary-adrenocortical activity in patients with diabetes mellitus. Arch Gen Psychiatr 41:1090-1095
35. Hudson JI, Hudson MS, Rothschild AJ, Vignati L, Scatzberg AF, Melby JC 1984 Abnormal results of dexamethasone suppression tests in nondepressed patients with diabetes mellitus. Arch Gen Psychiatr 41:1087-1089
36. Cameron OG, Thomas B, Tiongco D, Hariharan M, Greden JF 1987 Hypercortisolism in diabetes mellitus. Diabetes Care 10:662-664
37. Tsigos C, Young RJ, White A 1993 Diabetic neuropathy is associated with increased activity of the hypothalamic pituitary adrenal axis. J Clin Endocrinol Metab 76:554-558
38. Kaye TB, Rubin RA, Goldfine AB, Rajamani K, Kinsley BT, Vischer UM, Simonson DC 1992 Effect of glycaemic control on the overnight dexamethasone suppression test in patients with diabetes mellitus. J Clin Endocrinol Metab 41:640-644
39. Sperling MA, Bacon G, Kenny FM, Drash AL 1972 Cortisol secretion in acidotic and nonacidotic diabetes mellitus. Am J Dis Child 124:690-692
40. Couch RM 1992 Dissociation of cortisol and adrenal androgen secretion in poorly controlled insulin-dependent diabetes mellitus. Acta Endocrinol 127:115-117
41. Dullaart RBF, Ubels FL, Hoogenberg K, Smit AJ, Pratt JJ, Muntinga JHJ, Sluiter WJ, Wolthers BG 1995 Alterations in cortisol metabolism in insulin-dependent diabetes mellitus: Relationship with metabolic control and estimated blood volume and effect of angiotensin-converting enzyme inhibition. J Clin Endocrinol Metab 80:3002-3008
42. Coiro V, Volpi R, Capretti L, Speroni G, Caffarra P, Scaglioni A, Malvezzi L, Castelli A, Caffarri G, Rossi G, Chiodera P 1995 Low dose ovine corticotrophin-releasing hormone stimulation test in diabetes mellitus with and without neuropathy. Metabolism 44:538-542
43. Roy MS, Roy A, Brown S 1998 Increased urinary free cortisol output in diabetic patients. J Diabetes Complicat 12:24-27
44. Kerstens MN, Riemens SC, Sluiter WJ, Pratt JJ, Wolthers BG, Dullaart RBF 2000 No relation between 11β-hydroxysteroid dehydrogenase setpoint and insulin sensitivity in the basal state and after 24 hour of insulin infusion in healthy subjects and type 2 diabetic patients. Clin Endocrinol 52:403-411
45. Noon JP, Evans CE, Haynes WG, Webb DJ, Walker BR 1996 A comparison of techniques to assess skin blanching following topical application of glucocorticoids. Br J Dermatol 134:837-842
46. McConway MG, Chapman RS 1986 Development and evaluation of a simple, direct, solid-phase radioimmunoassay of serum cortisol from readily available reagents. Clin Chim Acta 158:59-70
47. Best R, Walker BR 1997 Additional value of measurement of urinary cortisone and unconjugated cortisol metabolites in assessing the activity of 11β-hydroxysteroid dehydrogenase in vivo. Clin Endocrinol (Oxf) 47:231-236
48. Zumoff B, Fukushima DK, Hellman L 1974 Intercomparison of four methods for measuring cortisol production. J Clin Endocrinol Metab 38:169-175
49. Ulick S, Tedde R, Wang JZ 1992 Defective ring A reduction of cortisol as the major metabolic error in the syndrome of apparent mineralocorticoid excess. J Clin Endocrinol Metab 74:593-599
50. Palermo M, Shackleton CHL, Mantero F, Stewart PM 1996 Urinary free cortisone and the assessment of 11β-hydroxysteroid dehydrogenase activity in man. Clin Endocrinol (Oxf) 45:605-611
51. Roy MS, Roy A, Gallucci WT, Collier B, Young K, Kamilaris TC, Chrousos GP 1993 The ovine corticotrophin-releasing hormone stimulation test in type 1 diabetic patients and controls: Suggestion of mild hypercortisolism. Metabolism 42:696-700
52. Faiman C, Moorhouse JA 1967 Diurnal variation in the levels of glucose and related substances in healthy and diabetic subjects during starvation. Clin Sci 32:111-126
53. Dacou-Voutetakis C, Peppa-Patrikiou M, Dracopoulou M 1998 Urinary free cortisol and its nyctohumeral variation in adolescents and young adults with IDDM; relation to endothelin 1 and indices of diabetic angiopathy. J Pediatr Endocrinol Metab 11:437-445
54. Asfeldt VH 1972 Hypophyseo-adrenocortical function in diabetes mellitus. Acta Med Scand 191:349-354
55. Serio M, Tarquini B, Contini P, Bucalossi A, Toccafondi R 1968 Plasma cortisol response to insulin and circadian rhythm in diabetic subjects. Diabetes 17:124-126
56. Deleted in proof.
57. Huther KJ, Scholz HR 1970 Plasma concentrations and rates of plasma clearance and production of cortisol and corticosterone in healthy persons and in subjects with asymptomatic and clinical diabetes mellitus. Horm Metab Res 2:357-363
58. Drejer J, Hendriksen C, Nielson LM, Binder C, Hager J, Kehlet H 1977 Diurnal variations in plasma prolactin, growth hormone, cortisol and blood glucose in labile diabetes mellitus. Clin Endocrinol (Oxf) 6:57-64
59. Jessop DS, Dallman MF, Fleming D, Lightman SL 2001 Resistance to glucocorticoid feedback in obesity. J Clin Endocrinol Metab 86:4109-4114
60. Livingstone DEW, Jones GC, Smith K, Andrew R, Kenyon CJ, Walker BR 2000 Understanding the role of glucocorticoids in obesity: Tissue-specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology 141:560-563
61. Stewart PM, Boulton A, Kumar S, Clark PMS, Shackleton CHL 1999 Cortisol metabolism in human obesity: Impaired cortisone-cortisol conversion in subjects with central adiposity. J Clin Endocrinol Metab 84:1022-1027
62. Livingstone DEW, Kenyon CJ, Walker BR 2000 Mechanisms of dysregulation of 11β-hydroxysteroid dehydrogenase type 1 in Zucker obese rats. J Endocrinol 167:533-539
63. Tomlinson JW, Moore J, Cooper MS, Bujalska I, Shahmanesh M, Burt C, Strain A, Hewison M, Stewart PM 2001 Regulation of expression of 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue: Tissue-specific induction by cytokines. Endocrinology 142:1982-1989
64. Bujalska IJ, Kumar S, Stewart PM 1997 Does central obesity reflect 'Cushing's disease of the omentum'? Lancet 349:1210-1213
65. Brown PH, Teelucksingh S, Matusiewicz SP, Greening AP, Crompton GK, Edwards CRW 1991 Cutaneous vasoconstrictor response to glucocorticoids in asthma. Lancet 337:576-580
66. Panarelli M, Holloway CD, Fraser R, Connell JMC, Ingram MC, Anderson NH, Kenyon CJ 1998 Glucocorticoid receptor polymorphism, skin vasoconstriction, and other metabolic intermediate phenotypes in normal human subjects. J Clin Endocrinol Metab 83:1846-1852
67. Ebrecht M, Buske-Kirschbaum A, Hellhammer DH, Kern S, Rohleder N, Walker BR, Kirschbaum C 2000 Tissue specificity of glucocorticoid sensitivity in healthy adults. J Clin Endocrinol Metab 85:3733-3739
68. Nyirenda MJ, Lindsay RS, Kenyon CJ, Burchell A, Seckl JR 1998 Glucocorticoid exposure in late gestation permanently programs rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring. J Clin Invest 101:2174-2181
69. Reynolds RM, McKeigue PM, Lithell HO, Chapman KE, Seckl JR, Walker BR 2002 Increased glucocorticoid receptor expression in skeletal muscle of men with cardiovascular risk factors. JAMA 287:2505-2506
70. Whorwood CB, Donovan SJ, Flanagan D, Phillips DIW, Byrne CD 2002 Increased glucocorticoid receptor expression in human skeletal muscle cells may contribute to the pathogenesis of the metabolic syndrome. Diabetes 51:1066-1075